Lipitor goes generic: business as usual or more big business?

Ann Intern Med. 2012 Jun 19;156(12):892-3, W313. doi: 10.7326/0003-4819-156-12-201206190-00420.
No abstract available

MeSH terms

  • Anticholesteremic Agents / economics*
  • Atorvastatin
  • Drug Industry / economics*
  • Drugs, Generic / economics*
  • Heptanoic Acids / economics*
  • Humans
  • Insurance Coverage / economics
  • Medicare Part D / economics
  • Prescription Fees*
  • Pyrroles / economics*
  • United States

Substances

  • Anticholesteremic Agents
  • Drugs, Generic
  • Heptanoic Acids
  • Pyrroles
  • Atorvastatin